NCT05516082

Clinical Evaluation of Two Daily Disposable Lenses in Sphere Design

Name: Clinical Trial NCT05516082
Creator: Coopervision, Inc.
Keywords: Ametropia, Lens A, device, clinical trial, Mexico

Coopervision, Inc.·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Ametropia
Drug/Device/Intervention: Lens A
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: Coopervision, Inc.
Location: Mexico City, Mexico

Timeline & enrollment

Phase: N/A
Start date: Dec 01, 2022
End date: Dec 01, 2022
Enrollment: 40 participants

Primary outcome

Overall Lens Fit Acceptance

Summary

The aim of this study is to evaluate the patient subjective experiences of the daily disposable hydrogel lens when compared to the daily disposable silicone hydrogel lens after 15 minutes of daily wear each.

ICD-10 classifications

Amblyopia ex anopsiaAmoebiasisAmoebiasis, unspecifiedMyoclonusOesophagitis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05516082
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT05516082 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Recruiting. The study focuses on Ametropia. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.